You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Serotonin Reuptake Inhibitor Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: Serotonin Reuptake Inhibitor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CELEXA citalopram hydrobromide TABLET;ORAL 020822-001 Apr 27, 2000 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie CELEXA citalopram hydrobromide TABLET;ORAL 020822-002 Jul 17, 1998 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie CELEXA citalopram hydrobromide TABLET;ORAL 020822-003 Jul 17, 1998 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie CELEXA citalopram hydrobromide TABLET;ORAL 020822-004 Jul 17, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077031-003 Oct 28, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077654-001 Feb 27, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd Iii CITALOPRAM HYDROBROMIDE citalopram hydrobromide SOLUTION;ORAL 201450-001 Dec 15, 2015 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.